Ozanimod CAS 1306760-87-1

Khoom Piav Qhia:

Khoom Lub Npe: Ozanimod CAS TSIS TAU: 1306760-87-1

Lub ntsiab lus:

RPC-1063;

(S) -5- (3- (1-((2-hydroxyethyl) amino) -2,3-dihydro-1H-inden-4-yl) -1,2,4-oxadiazol-5-yl) -2 -isopropoxybenzonitrile;

Benzonitrile, 5- [3-[(1S) -2,3-dihydro-1-[(2-hydroxyethyl) amino] -1H-inden-4-yl] -1,2,4-oxadiazol-5-yl] -2- (1-methylethoxy)-;

Tshuaj& Lub Cev Muaj Zog:

Tshwm sim: Khoom

Kev Ntsuas: ≥99.0%

Ceev: 1.30 ± 0.1 g/cm3 (Kwv yees)

Cov Kub Kub: 648.3 ± 65.0 ℃ (Kwv yees)

PKa: 14.73 ± 0.10 (Kwv yees)

Flash Point: 345.9 ± 34.3 ℃

Vapor Siab: 0.0 ± 2.0 mmHg ntawm 25 ℃

Index ntawm Refraction: 1.635

Ozamode yog qhov muaj peev xwm phossphynosin-1 receptor agonist rau kev kho mob ntau yam sclerosis (MS) thiab mob plab hnyuv uas ua rau muaj tshuaj lom nyob hauv phau ntawv cais ntawm cov hlab ntshav sab hauv lymphocytes, txo tus naj npawb ntawm cov lymphocytes nkag mus rau hauv txoj hnyuv. Raws li cov txiaj ntsig ntxaws ntxaws los ntawm Touchstone Consolidation Phase, cov neeg mob kho nrog Ozamod muaj lub hom phiaj kho mob siab dua lossis tus nqi sclera ntawm lub lim tiam 32 dua li cov kho nrog cov placebo. Ozamod tau siv los kho ntau yam sclerosis, mob plab hnyuv thiab Crohn' tus kab mob. Ntawm lawv, ntau yam sclerosis thiab mob plab tsis yog tsuas yog muaj kab mob ntev, tshwm sim ntau, thiab xav tau tshuaj ntau xyoo. Pom tau, Ozamod kev lag luam muaj peev xwm loj heev, kev cia siab yog qhov txiav txim siab ntau.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: ozanimod cas 1306760-87-1, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: EED226 CAS 2083627-02-3
• Tom ntej: LJN 452 CAS 1383816-29-2